PEPRX101
Rare Diseases
In-vitroPreclinical
Key Facts
About Peptris Technologies Private
AI-driven drug discovery company using proprietary generative AI to design novel molecules and repurpose drugs for oncology, inflammation, and rare diseases.
View full company profileTherapeutic Areas
Other Rare Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Drug Development Program | MindMaze Therapeutics | Research |
| RareScan | Constantiam Bio | Research |
| Undisclosed Rare Disease Program(s) | Base4 | Preclinical |
| Prognos Rare Disease | Prognos | Commercial |